U. Mach

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

Thomas Boraud, Christian Gross, Holger Stark, 2003, Nature Medicine.

H (0) blood group determinant is present on soluble human L‐selectin expressed in BHK‐cells

W. Reutter, R. Tauber, C. Fieger, 1999, FEBS letters.

Development of Novel 1,2,3,4‐Tetrahydroisoquinoline Derivatives and Closely Related Compounds as Potent and Selective Dopamine D3 Receptor Ligands

P. Sokoloff, J. Schwartz, H. Stark, 2004, Chembiochem : a European journal of chemical biology.

Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.

Holger Stark, H. Stark, T. Calmels, 2007, Bioorganic & medicinal chemistry.

Synthesis and Pharmacological Evaluation of 8‐ and 9‐Substituted Benzolactam‐V8 Derivatives as Potent Ligands for Protein Kinase C, a Therapeutic Target for Alzheimer's Disease

P. Blumberg, A. Kozikowski, N. Lewin, 2006, ChemMedChem.

Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.

E. Bézard, G. Fisone, B. Bioulac, 2005, Parkinsonism & related disorders.